From Faulding Pharmaceuticals to Mayne Pharma

The history of Mayne Pharma is intricate and began with FH Faulding & Co Ltd. 

From 1845 until 2001, Mayne Pharma was known as FH Faulding & Co where amongst other activities including pharmaceutical wholesaling and consumer health products, it built success around optimising the delivery of oral dosage form drugs.

In 2001, Mayne Group Ltd acquired FH Faulding & Co and then in November 2005, Mayne Group Ltd demerged the business into:

- Mayne Pharma Limited; a global pharmaceutical company focused on research and development, manufacture, marketing and distribution of injectable and oral pharmaceuticals; and

- Symbion Health Limited - a large Australian healthcare-focused company with leading market positions in pathology, diagnostic imaging, pharmacy and health-related consumer products.

In February 2007, Hospira Inc announced that it had completed the acquisition of Mayne Pharma Limited as it tied in with the firms skills in specialty generic injectible pharmaceuticals.

However in November 2009, the oral pharmaceutical group of Mayne Pharma Limited was purchased from Hospira by Halcygen Pharmaceuticals Ltd.

In November 2010, HalcyGen Pharmaceuticals changed its name to Mayne Pharma Group Limited, which is listed on the Australian Stock Exchange under the ASX code “MYX”.